Armata Pharmaceuticals Q3 EPS $(0.24) Beats $(0.56) Estimate, Sales $3.171M Beat $450.000K Estimate
Benzinga Newsdesk 11 hours ago
NewsEarningsEarnings Beats
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.56) by 57.14 percent. This is a 67.57 percent increase over losses of $(0.74) per share
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.56) by 57.14 percent. This is a 67.57 percent increase over losses of $(0.74) per share from the same period last year. The company reported quarterly sales of $3.171 million which beat the analyst consensus estimate of $450.000 thousand by 604.67 percent. This is a 173.60 percent increase over sales of $1.159 million the same period last year.